Delivery Order SPE2DB20D3505-SPE2DB25FU0V4
Award Date
2/27/25
Potential Completion Date
2/28/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,434.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a $4,695.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, with a period of performance through March 3, 2025. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical products. The contract has a ceiling value of $3,367.82 and a completion date of January 3, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical products. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $21,986.28 and a performance period through January 8, 2025. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award, valued at $7,275.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, for the provision of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical supplies. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,159.00, is a delivery order that provides the ADBRY 300 MG/2 ML AUTOINJECTOR 2ML pharmaceutical product. It has a performance period through November 1, 2024 and uses a firm fixed price pricing arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of an autoinjector product (ADBRY 300 MG/2 ML AUTOINJECTOR 2ML) with a ceiling value of $19,912.70 and a period of performance through February 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This federal contract award, valued at $2,041.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price contract. The award was not designated with a set-aside requirement, indicating open competition....
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,297.57 fixed-price delivery order contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with a completion date of May 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,041.76 firm fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...